BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28302043)

  • 21. Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.
    Xie W; Agniel D; Shevchenko A; Malov SV; Svitin A; Cherkasov N; Baum MK; Campa A; Gaseitsiwe S; Bussmann H; Makhema J; Marlink R; Novitsky V; Lee TH; Cai T; O'Brien SJ; Essex M
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):597-609. PubMed ID: 28132517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy.
    Reis EC; da Silva LT; da Silva WC; Rios A; Duarte AJ; Oshiro TM; Crovella S; Pontillo A
    Hum Vaccin Immunother; 2018; 14(8):1995-2002. PubMed ID: 29641325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral therapy immunologic non-response in a Brazilian population: association study using pharmaco- and immunogenetic markers.
    Coelho AVC; Moura RR; Guimarães RL; Brandão LAC; Crovella S
    Braz J Infect Dis; 2018; 22(5):392-401. PubMed ID: 30392849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of single-nucleotide polymorphisms in TLR7 (Gln11Leu) and TLR9 (1635A/G) with a higher CD4T cell count during HIV infection.
    Said EA; Al-Yafei F; Zadjali F; Hasson SS; Al-Balushi MS; Al-Mahruqi S; Koh CY; Al-Naamani K; Al-Busaidi JZ; Idris MA; Balkhair A; Al-Jabri AA
    Immunol Lett; 2014 Jul; 160(1):58-64. PubMed ID: 24747071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.
    Compaore TR; Soubeiga ST; Ouattara AK; Obiri-Yeboah D; Tchelougou D; Maiga M; Assih M; Bisseye C; Bakouan D; Compaore IP; Dembele A; Martinson J; Simpore J
    PLoS One; 2016; 11(1):e0146386. PubMed ID: 26741797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief Report: Toll-like Receptor 9-1635A/G Polymorphism Is Associated With HIV-1 Rebound After Four Weeks of Interruption of Antiretroviral Therapy.
    Vallejo A; Molina-Pinelo S; de Felipe B; Abad-Fernández M; González-Escribano MF; Leal M; Soriano-Sarabia N
    J Acquir Immune Defic Syndr; 2020 Oct; 85(2):252-256. PubMed ID: 32658127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.
    Cho SJ; Drechsler H; Burke RC; Arens MQ; Powderly W; Davidson NO
    J Virol; 2006 Feb; 80(4):2069-72. PubMed ID: 16439564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of CD209L tandem repeats polymorphism with susceptibility to human immunodeficiency virus-1 infection, disease progression, and treatment outcomes: a Moroccan cohort study.
    Fayssel N; Bensghir R; Ouladlahsen A; Abdelghaffar H; Sodqi M; Lahlou K; Benjelloun S; Marhoum El Filali K; Ezzikouri S; Wakrim L
    Clin Microbiol Infect; 2015 May; 21(5):513.e1-5. PubMed ID: 25656622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of H186R polymorphism in exon 4 of the APOBEC3G gene among North Indian individuals.
    Rathore A; Chatterjee A; Yamamoto N; Dhole TN
    Genet Test; 2008 Sep; 12(3):453-6. PubMed ID: 18652534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIM5 gene polymorphisms in HIV-1-infected patients and healthy controls from Northeastern Brazil.
    Celerino da Silva R; Coelho AV; Arraes LC; Brandão LA; Crovella S; Guimarães RL
    Immunol Res; 2016 Dec; 64(5-6):1237-1242. PubMed ID: 27388872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy.
    Di Biagio A; Rusconi S; Marzocchetti A; Signori A; Schiavetti I; Bruzzone B; Monno L; Punzi G; Colao MG; Penco G; Zazzi M; De Luca A;
    J Med Virol; 2014 Oct; 86(10):1648-55. PubMed ID: 25042976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study.
    Obirikorang C; Acheampong E; Quaye L; Yorke J; Amos-Abanyie EK; Akyaw PA; Anto EO; Bani SB; Asamoah EA; Batu EN
    PLoS One; 2020; 15(1):e0227779. PubMed ID: 31929604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAS -670 A/G polymorphism may be associated with the depletion of CD4(+) T lymphocytes in HIV-1 infection.
    Hermes RB; Santana BB; Lima SS; Neris Martins Feitosa R; de Oliveira Guimarães Ishak M; Ishak R; Vallinoto AC
    Hum Immunol; 2015 Oct; 76(10):742-6. PubMed ID: 26429326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Laboratory testing including CD4 T-cell count and determination of viral load to evaluate the impact of first line antiretroviral treatment at 6 months in adults in Benin].
    Ogouyemi-Hounto A; Zannou D; Metodakou D; Lafia B; Gomez V; Akinocho E
    Med Trop (Mars); 2010 Feb; 70(1):100. PubMed ID: 20337131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequencies of IL10 SNP genotypes by multiplex PCR-SSP and their association with viral load and CD4 counts in HIV-1-infected Thais.
    Kingkeow D; McNicholl JM; Maneekarn N; Wongtrakul J; Taechareonkul S; Suriyanon V; Nelson KE; Duerr A; Makonkawkeyoon S
    Asian Pac J Allergy Immunol; 2011 Mar; 29(1):94-101. PubMed ID: 21560494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4 intragenic SNPs associate with HIV-2 plasma viral load and CD4 count in a community-based study from Guinea-Bissau, West Africa.
    Hennig BJ; Velez-Edwards DR; Schim van der Loeff MF; Bisseye C; Edwards TL; Tacconelli A; Novelli G; Aaby P; Kaye S; Scott WK; Jaye A; Whittle HC; Williams SM; Hill AV; Sirugo G
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):1-8. PubMed ID: 20924289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Polymorphisms in the Regulatory Region of the Cyclophilin a Gene (PPIA) with Gene Expression and HIV/AIDS Disease Progression.
    Madlala P; Singh R; An P; Werner L; Mlisana K; Abdool Karim SS; Winkler CA; Ndungʼu T
    J Acquir Immune Defic Syndr; 2016 Aug; 72(5):465-73. PubMed ID: 27088296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of TLR4 (1063A/G and 1363C/T) polymorphisms in healthy and HIV-infected Omani individuals and their relationship to viral load and T cell count.
    Said EA; Al-Yafei F; Zadjali F; Al-Balushi MS; Hasson SS; Al-Mahroqi SH; Koh CY; Al-Naamani K; Al-Busaidi JZ; Idris MA; Balkhair A; Al-Jabri AA
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.
    de Lourdes Teixeira M; Nafea S; Yeganeh N; Santos E; Gouvea MI; Joao E; Ceci L; Bressan C; Cruz ML; Sidi LC; Nielsen-Saines K
    Int J STD AIDS; 2015 Nov; 26(13):922-8. PubMed ID: 25504831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of adiponectin-encoding gene ADIPOQ single nucleotide polymorphisms +45 and +276 on serum lipid levels after antiretroviral therapy in Japanese patients with HIV-1-infection.
    Kato H; Ohata A; Samukawa S; Ueda A; Ishigatsubo Y
    J Int Med Res; 2016 Apr; 44(2):297-306. PubMed ID: 26831403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.